Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Pet Deal benchmark

<< Previous

Bullboard Posts

Next >>

Comment by noclue80on Oct 24, 2022 3:21pm

157 Views

Post# 35044595

RE:RE:RE:RE:Pet Deal benchmark

seems this BexCaFe was implemented just for this deal.. is that common if you don't want to disclose the original rights owner..?

also, none of the materials talk about SGLT2 specifically, just oral treatment for feline diabetes. the first-in-class, oral daily might indicate it is SGLT2, but it's ot written anywhere..

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"